pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
pharmadog news

Browse

2,984 stories matching this filter · ← front page

★ save view↓export CSV
rangeto
sort
recentoldestsourcealpha
source
STAT1777Endpoints1386Fierce Biotech705BioSpace697BioPharma Dive524raps234onclive165fda recalls113
therapy area
allOncology12301Rare Disease3205Immunology2862Cardiology2733Hematology2177Pulmonology2138Vaccines
  • Pope’s AI Encyclical Offers Guidance for Catholic Hospitals and Health Care
    The article notes that Pope Francis released an encyclical addressing artificial intelligence and examines what that means for Catholic hospitals and the broader health‑care system. STAT’s AI Prog…
    STAT · 5mo agoNeutral↗ source
  • Concerns arise that military practices may contribute to eating disorders amid broader health updates
    The Morning Rounds newsletter, written by Theresa Gaffney, raises a question about whether military environments are encouraging eating disorders. The piece is part of a daily health briefing that…
    STAT · 5mo agoNeutral↗ source
← prev
page 100 of 120
next →
fda medwatch111
globenewswire health73
fda press59
1794
Psychiatry & CNS1204
Ophthalmology1051
Pain777
Endocrinology & Metabolism775
Nephrology760
Researchers urge sweeping policy action on ultra-processed foods after poll shows bipartisan concern
A special edition of the American Journal of Public Health brings together leading researchers on ultra-processed foods and delivers a clear message to policymakers: take action now. Food policy s…
STAT · 5mo agoRegulatoryNeutral↗ source
  • Rising AI battle between hospitals and insurers drives soaring medical bills, says pediatric cardiologist
    Darshak Sanghavi, a pediatric cardiologist and chief medical officer of Machinify, writes an opinion piece about an emerging AI conflict between health providers and insurers over patient records a…
    STAT · 5mo agoNegative↗ source
  • Military culture may increase risk of eating disorders among men, expert warns
    Paula Chesley, a yoga and meditation instructor who works with people with eating disorders, notes that male clients are rare but many have served in the military. She says that, based on her expe…
    STAT · 5mo agoNegative↗ source
  • Public health must address the rapidly growing Amish population, experts say
    The STAT First Opinion podcast highlighted that the Amish community is expanding quickly, roughly doubling every two decades, which will increasingly affect public health planning. Researchers Bra…
    STAT · 5mo agoNeutral↗ source
  • Longevity startup NewLimit secures $435 million Series C as it prepares first liver drug trial
    NewLimit, a longevity‑focused biotech founded in 2021, announced a Series C financing that brought in $435 million, pushing its valuation to about $3.1 billion. The round was led by Founders Fund…
    STAT · 5mo agoDealPositive↗ source
  • Radiopharmaceutical shows promise after Pluvicto; Vera Therapeutics gains FDA agreement to speed IgA nephropathy data analysis
    A new radiopharmaceutical is generating interest for use after patients have completed Pluvicto therapy, suggesting a potential follow‑on treatment option. Abivax reported encouraging results from…
    STAT · 5mo agoRegulatoryNeutral↗ source
  • Eli Lilly warns 340B hospitals to submit claims data within five days or lose price discounts
    Eli Lilly has given roughly 50 hospitals that participate in the federal 340B drug discount program a five‑day deadline to provide comprehensive claims data. The company says that if the data are n…
    STAT · 5mo agoRegulatoryNegative↗ source
  • Trump administration releases Medicaid work-requirement rules, prompting state compliance challenges
    The Morning Rounds newsletter highlighted several health‑policy developments, notably new Medicaid work‑requirement rules and fast‑tracked funding for experimental Ebola vaccines. The Trump admini…
    STAT · 5mo agoRegulatoryNeutral↗ source
  • States tighten rules on corporate telehealth, targeting business structures behind direct-to-consumer care
    Telehealth has grown into a multibillion‑dollar industry, with brands like Hims & Hers and Teladoc becoming widely recognized. Despite their visibility, many patients are unaware that corporate te…
    STAT · 5mo agoRegulatoryNegative↗ source
  • Telemedicine surge could eliminate traditional doctor’s office waiting rooms
    Emergency physician Iyesatta Massaquoi Emeli reflects on how the concept of waiting has been built into medical practice, from the lobby to the triage process, shaping patients' experience of care.…
    STAT · 5mo agoPositive↗ source
  • Medicare launches $50/month coverage for Wegovy and Zepbound but withholds cost to taxpayers
    Medicare announced a temporary “GLP-1 Bridge” program that will allow adults 65 and older to receive the obesity treatments Wegovy and Zepbound for $50 a month beginning July 1. The program runs t…
    STAT · 5mo agoRegulatoryNegative↗ source
  • Abivax’s ulcerative colitis pill shows high remission rates but cancer cases spark safety worries
    Abivax reported that its experimental oral therapy for ulcerative colitis achieved strong efficacy in a Phase 3 maintenance trial involving 580 patients who had previously responded in shorter stud…
    STAT · 5mo agoNegative readoutNegative↗ source
  • ASCO Highlights Barriers to Cancer Care and New Treatments Amid Memorable Pancreatic Cancer Study Ovation
    The annual ASCO meeting featured extensive discussion of the obstacles patients face in accessing cancer care and showcased a range of emerging therapies. STAT compiled a quick‑take newsletter tha…
    STAT · 5mo agoNeutral↗ source
  • Revolution Medicines reports pancreatic cancer drug daraxonrasib extends median survival to 13.2 months in second-line study
    Revolution Medicines released detailed data confirming that its experimental pancreatic cancer therapy, daraxonrasib, improved overall survival for patients with advanced disease. In the second‑lin…
    STAT · 5mo agoPositive readoutPositive↗ source
  • Daraxonrasib shows promising pancreatic cancer results as Chinese lung therapy exceeds expectations
    The latest ASCO updates highlighted detailed data on daraxonrasib, a drug targeting pancreatic cancer, indicating encouraging efficacy signals for patients. In parallel, a lung cancer treatment de…
    STAT · 5mo agoPositive readoutPositive↗ source
  • Servier to acquire Edgewise Therapeutics' muscular dystrophy program for up to $2.65 billion
    French pharma group Servier announced it will purchase Edgewise Therapeutics' muscular dystrophy business. The transaction is valued at up to $2.65 billion, comprising a $1.55 billion upfront cash…
    STAT · 5mo agoDealPositive↗ source
  • Eli Lilly gives hospitals five days to submit 340B claims data or lose discount pricing
    Eli Lilly has issued a notice to more than 1,000 hospitals that take part in the federal 340B drug discount program, requiring them to provide comprehensive claims data within five days. The compa…
    STAT · 5mo agoRegulatoryNegative↗ source
  • CEPI allocates $62 million to accelerate three Bundibugyo Ebola vaccine candidates
    CEPI announced it will provide roughly $62 million to three groups to speed the development of vaccines targeting the Bundibugyo strain of Ebola, which is currently spreading in the Democratic Repu…
    STAT · 5mo agoDealPositive↗ source
  • Medicare withholds cost data for senior GLP-1 obesity drugs as Massachusetts sues UnitedHealth
    Medicare announced that seniors can obtain Wegovy and Zepbound for $50 a month starting in July, but the agency has not disclosed how much the program will cost taxpayers. The absence of cost tran…
    STAT · 5mo agoRegulatoryNegative↗ source
  • ASCO meeting highlights grief alongside cancer data, honoring late oncologist Amy Lin
    At the annual American Society of Clinical Oncology meeting, scientists presented abundant new cancer data, but this year the program also gave space to the emotional side of oncology. Outgoing pr…
    STAT · 5mo agoNeutral↗ source
  • CDC prioritizes containing Ebola spread as Trump administration proposes grant overhaul
    The CDC announced that stopping the spread of Ebola remains its top priority, emphasizing containment measures as the virus continues to pose a threat. In parallel, the Trump administration releas…
    STAT · 5mo agoNeutral↗ source
  • Military medical corps faces recruitment crisis as physicians leave for higher civilian pay
    Retired rear admiral and former congressional physician Robert Krasner argues that the U.S. military’s medical workforce is in jeopardy. He says the war in Iran has highlighted a long‑standing shor…
    STAT · 5mo agoNegative↗ source
  • General Catalyst uses Summa Health as test bed for AI-driven patient support tools
    General Catalyst bought Ohio safety‑net hospital Summa Health in October and is using it to trial new health‑technology tools. Executives from the holding company, Health Assurance Transformation C…
    STAT · 5mo agoPositive↗ source